Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.38)
# 3,983
Out of 4,711 analysts
22
Total ratings
26.67%
Success rate
-27.46%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CELH Celsius Holdings | Maintains: Neutral | $72 → $68 | $27.01 | +151.76% | 2 | Oct 21, 2024 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.00 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $4.65 | - | 1 | Oct 5, 2023 | |
| CKPT Checkpoint Therapeutics | Maintains: Buy | $65 → $47 | $3.75 | +1,153.33% | 2 | Aug 15, 2023 | |
| VERO Venus Concept | Maintains: Buy | $49 → $33 | $0.32 | +10,126.22% | 2 | Mar 28, 2023 | |
| ZYXI Zynex | Maintains: Buy | $27 → $28 | $8.25 | +239.39% | 1 | Mar 28, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $1.72 | +5,132.56% | 1 | Aug 4, 2022 | |
| ECOR electroCore | Initiates: Buy | $45 | $15.27 | +194.70% | 1 | Jul 27, 2021 | |
| HROW Harrow | Initiates: Buy | $14 | $34.22 | -58.36% | 1 | Jul 2, 2021 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.54 | +354.55% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $6.76 | +669.23% | 1 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11,025 | $0.32 | +3,443,060.52% | 1 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $5.49 | +27.50% | 1 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.61 | - | 1 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $68.63 | - | 5 | Apr 27, 2017 |
Celsius Holdings
Oct 21, 2024
Maintains: Neutral
Price Target: $72 → $68
Current: $27.01
Upside: +151.76%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.00
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.65
Upside: -
Checkpoint Therapeutics
Aug 15, 2023
Maintains: Buy
Price Target: $65 → $47
Current: $3.75
Upside: +1,153.33%
Venus Concept
Mar 28, 2023
Maintains: Buy
Price Target: $49 → $33
Current: $0.32
Upside: +10,126.22%
Zynex
Mar 28, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $8.25
Upside: +239.39%
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $1.72
Upside: +5,132.56%
electroCore
Jul 27, 2021
Initiates: Buy
Price Target: $45
Current: $15.27
Upside: +194.70%
Harrow
Jul 2, 2021
Initiates: Buy
Price Target: $14
Current: $34.22
Upside: -58.36%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.54
Upside: +354.55%
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $6.76
Upside: +669.23%
Jun 26, 2020
Initiates: Buy
Price Target: $11,025
Current: $0.32
Upside: +3,443,060.52%
Sep 25, 2017
Initiates: Buy
Price Target: $7
Current: $5.49
Upside: +27.50%
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $5.61
Upside: -
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $68.63
Upside: -